Author: Eric Sheetz

Rhode Island Governor Nominates Three for Cannabis Regulatory Board

The governor of Rhode Island on Wednesday nominated three individuals to a regulatory panel that will oversee the state’s legal marijuana programs. Gov. Dan McKee, a Democrat, announced his appointments to the Rhode Island Cannabis Control Commission, which “will oversee the regulation, licensing and control of adult use and medical cannabis in the Ocean State,” […]

Groups Push Senators To Add Marijuana Business Stock Exchange Access To Banking Bill

A coalition of marijuana advocacy groups is asking that a bipartisan marijuana banking bill be expanded to include provisions ensuring that cannabis businesses have access to all forms of financial services—including the ability to be listed on senior U.S. stock exchanges. In a letter sent to Senate Banking Committee leadership on Thursday, the coalition SAFE […]

DEA States New Rules for Synthetic Cannabinoids

The Drug Enforcement Administration (DEA) recently announced at the 2023 Supply Chain Conference in Houston, Texas that it will soon unveil new rules regarding synthetic cannabinoids. The DEA’s Section Chief of Drug and Chemical Evaluation Section, Terrance Boos, spoke on the topic of emerging trends at the conference on May 4. Boos confirmed that the […]

Weed Legalization Has Contributed to a Decrease in Tobacco Use

A study published in the Journal of Health Economics addresses the topic of tobacco use in the wake of cannabis legalization. Entitled “Have recreational marijuana laws undermined public health progress on adult tobacco use?” researchers found that cannabis reform in individual states has led to decreased tobacco use. The study was conducted by Bentley University, […]

Connecticut Takes in $21 Million in Legal Weed Sales for April

Legal marijuana sales in Connecticut remain stable, with the state reporting $21 million in revenue from medical and adult-use cannabis in April. The figures, reported on Wednesday by the state Department of Consumer Protection, showed that the newly launched adult-use market recorded $10.2 million in the month of April, while the medical cannabis market brought […]

Psilocybin Research Approved in Arizona Appropriations Act Budget

Arizona senators voted to approve a general appropriations act 2023-2024 on May 10. Within the appropriations bill is a multitude of funding proposals from the governor’s office, which includes everything from Alzheimer’s disease research ($4.1 million), a newborn screening program ($12 million), and the Arizona nurse education investment pilot program ($15 million), but it also […]